课题基金 / 基金详情

项目摘要

项目成果

GUANG-XIAN ZHANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Flow Cytometry and Cell Sorting Core will provide standard technology and analysis services to the Philadelphia ACE investigators. This core will be used by both research projects, both clinical components and the pilot research project. It is non-duplicative of other services or facilities available to ACE investigators. The Core will be built around a state-of-the-art sorting system that has fixed alignment of the three laser beams (for the blue, red, and UV lasers), which can perform multi-color analysis (up to 13) in a single cell and simultaneously sort 4 subpopulations with high purity, high recovery, high speed, and sterile cell sorting, thus being essential for the experiments proposed in projects by the Pis. The core resources are not otherwise available at the Thomas Jefferson University or through other grant mechanisms. Two certified specialists, including the Core Director and one full-time research assistant, will routinely run this core to provide high-quality service. The goals of the Flow Cytometry and Cell Sorting Core are to: 1) Offer high quality and affordably priced services for analysis and sorting of a range of cell types, with particular emphasis on immune cells according to the needs of autoimmunity investigators in the ACE; 2) Consult with ACE members to determine their individual analytical cytometry needs, to aid in the development of appropriate protocols and techniques, giving advice for both standard and specialized services; 3) Promote interaction and collaboration among investigators by providing a centralized facility where exchange of results and ideas will be facilitated. As flow cytometry will be extensively used by all the Pis, this well-equipped core, in both machine and personnel, will provide a powerful tool for the overall success of this ACE.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ursolic acid: a novel oral therapy for chronic stage of MS/EAE by both immunomodulation and neural repair
  • 批准号:
    9923753
  • 项目类别:
  • 资助金额:
    $34.13万
  • 财政年份:
    2017
  • 负责人:
    GUANG-XIAN ZHANG
  • 依托单位:
Ursolic acid: a novel oral therapy for chronic stage of MS/EAE by both immunomodulation and neural repair
  • 批准号:
    9384085
  • 项目类别:
  • 资助金额:
    $34.13万
  • 财政年份:
    2017
  • 负责人:
    GUANG-XIAN ZHANG
  • 依托单位:
NSCs produce a triply effective cocktail in the CNS for MS/EAE therapy
  • 批准号:
    8849995
  • 项目类别:
  • 资助金额:
    $30.52万
  • 财政年份:
    2012
  • 负责人:
    GUANG-XIAN ZHANG
  • 依托单位:
NSCs produce a triply effective cocktail in the CNS for MS/EAE therapy
  • 批准号:
    8545912
  • 项目类别:
  • 资助金额:
    $29.45万
  • 财政年份:
    2012
  • 负责人:
    GUANG-XIAN ZHANG
  • 依托单位:
国内基金
海外基金
Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    黄朝凌
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    35万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    82060278
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    易成
  • 依托单位: